Preservation solution for lung transplantation.

Area of Science:

• Transplantation Medicine
• Cardiothoracic Surgery
• Organ Preservation

Background:

• Lung transplantation is a vital treatment for end-stage lung disease, yet 1-year survival is limited to 80%.
• Primary graft dysfunction (PGD) is a major cause of mortality, accounting for 30% of deaths post-transplant.
• Ischemia-reperfusion injury is a primary driver of PGD, highlighting the need for optimized lung preservation strategies.

Purpose of the Study:

• To review experimental and clinical studies on lung preservation techniques.
• To focus on the composition of preservation solutions used in clinical lung transplantation.
• To evaluate the shift towards extracellular fluid-type preservation solutions.

Main Methods:

• Literature review of experimental and clinical studies on lung preservation.
• Analysis of preservation solution composition and its impact on lung function.
• Comparison of intracellular vs. extracellular fluid-type preservation solutions.

Main Results:

• Lung preservation solution composition is critical for successful lung transplantation.
• Extracellular fluid-type preservation solutions are increasingly favored over intracellular types.
• These solutions demonstrate preferable post-transplant lung function.

Conclusions:

• Optimizing lung preservation solutions is key to reducing PGD and improving transplant outcomes.
• The use of extracellular fluid-type solutions represents a significant advancement in lung preservation.
• Further research and clinical application of these solutions are warranted to enhance long-term graft survival.